Core Laboratories N.V Stock Gaps Up On Today's Open (CLB)
Shares of Core Laboratories N.V (NYSE:CLB) were gapping up Thursday morning with an open price 10.8% higher than Wednesday's closing price. The stock closed at $126.24 yesterday and opened today's trading at $139.89.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Shares of Core Laboratories N.V (NYSE: CLB) were gapping up Thursday morning with an open price 10.8% higher than Wednesday's closing price. The stock closed at $126.24 Wednesday and opened today's trading at $139.89.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The average volume for Core Laboratories N.V has been 318,800 shares per day over the past 30 days. Core Laboratories N.V has a market cap of $5.97 billion and is part of the basic materials sector and energy industry. Shares are up 15.5% year to date as of the close of trading on Wednesday. Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry worldwide. The company has a P/E ratio of 28.6, above the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Core Laboratories N.V as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Core Laboratories N.V Ratings Report. Get more investment ideas from our investment research center. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.